Management of skeletal muscle injuries in military personnel

Operative Techniques in Sports Medicine

Volumn 13, Issue 4, 2005, Pages 247-256

  Gates, Charley ^a,b   Huard, Johnny ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Fibrosis; Inflammation; Military injury; Skeletal muscle

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; DECORIN; FLURBIPROFEN; GAMMA INTERFERON; GROWTH FACTOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; RELAXIN; SOMATOMEDIN C; SURAMIN; TRANSFORMING GROWTH FACTOR BETA1;

ABSENTEEISM; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL INTERACTION; CLINICAL PROTOCOL; CONNECTIVE TISSUE; CYTOKINE RELEASE; DRUG MECHANISM; FIBROBLAST; GASTROINTESTINAL HEMORRHAGE; HEALING; HEALTH CARE COST; HEART FAILURE; HEMATOMA; HUMAN; KIDNEY DYSFUNCTION; LIVER INJURY; MACROPHAGE; MILITARY SERVICE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE NECROSIS; MUSCLE REGENERATION; MUSCULOSKELETAL INJURY; MYOFIBROSIS; MYOSITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SOLDIER; T LYMPHOCYTE; TREATMENT OUTCOME; VIRAL GENE THERAPY;

EID: 33645867368     PISSN: 10601872     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.otsm.2006.01.012     Document Type: Article

References (129)

1. C. Kasemkijwattana J. Menetrey C.S. Day et. al. Biologic intervention in muscle healing and regeneration Sports Med Arthroscopy Rev 6 1998 95-102
2. C. Kasemkijwattana J. Menetrey G. Somogyl et. al. Development of approaches to improve healing following muscle contusion Cell Transplant 7 1998 585-598
3. J. Menetrey C. Kasemkijwattana F.H. Fu et. al. Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model Am J Sports Med 27 1999 222-229
4. T.A. Jarvinen M. Kaariainen M. Jarvinen et. al. Muscle strain injuries Curr Opin Rheumatol 12 2000 155-161
5. J.J. Crisco P. Jokl G.T. Heinen et. al. A muscle contusion injury model. Biomechanics, physiology, and histology Am J Sports Med 22 1994 702-710
6. K. Fukushima N. Badlani A. Usas et. al. The use of an anti-fibrosis agent to improve muscle recovery after laceration Am J Sports Med 29 2001 394-402
7. W.E. Garrett Jr A.V. Seaber J. Boswick et. al. Recovery of skeletal muscle after laceration and repair J Hand Surg (Am) 9 1984 683-692
8. W.E. Garrett Jr Muscle strain injuries: Clinical and basic aspects Med Sci Sports Exerc 22 1990 436-443
9. C. Hughes 4th C.T. Hasselman T.M. Best et. al. Incomplete, intrasubstance strain injuries of the rectus femoris muscle Am J Sports Med 23 1995 500-506
10. M. Jarvinen T. Sorvari Healing of a crush injury in rat striated muscle. Description and testing of a new method of inducing a standard injury to the calf muscles Acta Path Microbiol Scand (A) 83 1975 259-265
11. C.W. Lee K. Fukushima A. Usas et. al. Biological intervention based on cell and gene therapy to improve muscle healing after laceration J Musculoskeletal Res 4 2000 265-277
12. J. Menetrey C. Kasemkijwattana C.S. Day et. al. Growth factors improve muscle healing in vivo J Bone Joint Surg Br 82 2000 131-137
13. K.J. Miller D. Thaloor S. Matteson et. al. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle Am J Cell Physiol 278 2000 C174-C181
14. Nikalaou B.L. Macdonald R.R. Glisson et. al. Biomechanical and histological evaluation of muscle after controlled strain injury Am J Sports Med 15 1987 9-14
15. C. Kasemkijwattana J. Menetrey P. Bosch et. al. Use of growth factors to improve muscle healing after strain injury Clin Orthop 370 2000 272-285
16. J. Kellett Acute soft tissue injuries-a review of the literature Med Sci Sports Exec 18 1986 489-500
17. A. Arnason A. Gudmundsson H.A. Dahl et. al. Soccer injuries in Iceland Scand J Med Sci Sports 6 1996 40-45
18. C.A. Emery W.H. Meeuwisse J.W. Powell Groin and abdominal strain injuries in the National Hockey League Clin J Sport Med 9 1999 151-156
19. W.H. Meeuwisse R. Sellmer B.E. Hagel Rates and risks of injury during intercollegiate basketball Am J Sports Med 31 2003 379-385
20. C. Woods R.D. Hawkins S. Maltby et. al. The Football Association Medical Research Programme: An audit of injuries in professional football-analysis of hamstring injuries Br J Sports Med 38 2004 36-41
21. T.M. Best S.E. Shehadeh G. Leverson et. al. Analysis of changes in mRNA levels of myoblast- and fibroblast-derived gene products in healing skeletal muscle using quantitative reverse transcription-polymerase chain reaction J Orthop Res 19 2001 565-572
22. J.L. Croisier Factors associated with recurrent hamstring injuries Sports Med 34 2004 681-695
23. P. Peetrons Ultrasound of muscles Eur Radiol 12 2002 35-43
24. W.E. Garrett Jr T.M. Best Anatomy, physiology, and mechanics of skeletal muscle S.R. Simon Orthopaedic Basic Science 1994 American Academy of Orthopaedic Surgeons Rosemont, IL 89-125
25. J.L. Andersen P. Schjerling B. Saltin Muscle, genes and athletic performance Sci Am 283 2000 48-55
26. R. Bischoff The satellite cell and muscle regeneration A.G. Engel C. Franzini-Armstrong Myology. Basic and Clinical (ed 2) 1994 McGraw-Hill New York, NY 97-118
27. T. Hurme H. Kalimo Activation of myogenic precursor cells after muscle injury Med Sci Sports Exerc 24 1992 197-205
28. S. Carpenter G. Karpati Segmental necrosis and its demarcation in experimental micropuncture injury of skeletal muscle fibers J Neuropathol 48 1989 154-170
29. S. Orimo E. Hiyamuta K. Arahata et. al. Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis Muscle Nerve 14 1991 515-520
30. C. Ebisui T. Tsujinaka T. Morimoto et. al. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotbubes Clin Sci 89 1995 431-439
31. C. Mbebi D. Hantai M. Jandrot-Perrus et. al. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors J Cell Physiol 179 1999 305-314
32. M. Kaariainen T. Jarvinen M. Jarvinen et. al. Relation between myofibers and connective tissue during muscle injury repair Scand J Med Sci Sports 10 2000 332-337
33. T.L. Clanton L. Zuo P. Klawitter Oxidants and skeletal muscle function: Physiologic and pathophysiologic implications Proc Soc Exp Biol Med 222 1999 253-262
34. G.L. Warren D.A. Hayes D.A. Lowe et. al. Mechanical factors in the initiation of eccentric contraction-induced injury in rat soleus muscle Muscle Nerve 23 2000 521-528
35. J. Rantanen J. Ranne T. Hurme et. al. Denervated segments of injured skeletal muscle fibers are reinnervated by newly formed neuromuscular junctions J Neuropathol Exp Neurol 54 1995 188-194
36. R.A. Fielding T.J. Manfredi W. Ding et. al. Acute phase response in exercise. III. Neutrophil and IL-1 accumulation in skeletal muscle Am J Physiol 265 1993 R166-R172
37. J.G. Tidball Inflammatory cell response to acute muscle injury Med Sci Sports Exerc 27 1995 1022-1032
38. J. Frenette B. Cai J. Tidball Complement activation promotes muscle inflammation during modified muscle use Am J Pathol 156 2000 2103-2110
39. D.L. MacIntyre W.D. Reid D.M. Lyster et. al. Different effects of strenuous eccentric exercise on the accumulation of neutrophils in muscle in women and in men Eur J Appl Physiol 81 2000 47-53
40. H. Honda H. Kimura A. Rostam Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle Immunology 70 1990 272-277
41. B.M. Lapointe J. Frenette C.H. Cote Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion J Appl Physiol 92 2002 1995-2004
42. J.S. Beckman W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite The good, the bad, and ugly Am J Physiol 271 1996 C1424-C1437
43. V. Witko-Sarsat P. Rieu B. Descamps-Latscha et. al. Neutrophils: Molecules, functions, and pathophysiological aspects Lab Invest 80 2000 617-653
44. I.S. McLennan Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibers Cell Tissue Res 272 1993 193-196
45. B.A. St. Pierre J.G. Tidball Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension J Appl Physiol 77 1994 290-297
46. J. Huard Y. Li F.H. Fu Muscle injuries and repair: Current trends in research J Bone Jt Surg Am 84-A 2002 822-832
47. Y. Li J. Huard Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle Am J Pathol 161 2002 895-907
48. Z. Qu-Petersen B. Deasy R. Jankowski et. al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration J Cell Biol 157 2002 851-864
49. J. Rantanen J. Ranne T. Hurme Satellite cell proliferation and expression of myogenin and desmin in regenerating skeletal muscle: Evidence for two different populations of satellite cells Lab Invest 73 1995 341-347
50. P. Zammit J. Beauchamp The skeletal muscle satellite cell: Stem cell or son of stem cell? Differentiation 68 2001 193-204
51. S.M. Sheehan R.E. Allen Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor J Cell Physiol 181 1999 499-506
52. B.M. Deasy Z. Qu-Petersen J.S. Greenberger et. al. Mechanisms of muscle stem cell expansion with cytokines Stem Cells 20 2002 50-60
53. M.E. Doumit D.R. Cook R.A. Merkel Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells J Cell Physiol 157 1993 326-332
54. L. Mendler E. Zador M. Ver Heyen et. al. Myostatin levels in regenerating rat muscles and in myogenic cell cultures J Muscle Res Cell Motil 21 2000 551-563
55. K. Yamanouchi C. Soeta K. Naito Expression of myostatin gene in regenerating skeletal muscle of the rat and its localization Biochem Biophys Res Commun 270 2000 510-516
56. J.I. Jones D.R. Clemmons Insulin-like growth factors and their binding proteins Biological actions Endocr Rev 16 1995 3-34
57. S.E. Mutsaers J.E. Bishop G. McGrouther et. al. Mechanisms of tissue repair: From wound healing to fibrosis Int J Biochem Cell Biol 29 1997 5-17
58. P. Bernasconi E. Torchiana P. Confalonieri Expression of transforming growth factor beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine J Clin Invest 96 1995 1137-1144
59. A.M.B.C. Tiggleman C. Linthorst W. Boers et. al. Transforming growth factor-β induced collagen synthesis by human liver myofibroblasts inhibited by alpha-2-macroglobulin J Hepatol 26 1997 1220-1228
60. W.A. Border N.A. Noble Transforming growth factor beta in tissue fibrosis N Engl J Med 10 1994 1286-1292
61. A. Pandit R. Ashar D. Feldman The effect of TGF-β delivered through a collagen scaffold on wound healing J Invest Surg 12 1999 9-100
62. Y. Li W. Foster K. Sato et. al. Non-viral mediated gene transfer of TGF-B1 promotes the differentiation of muscle derived cells toward fibroblastic lineage and muscle fibrosis Mol Ther 3 2001 278
63. Y. Li W. Foster B.M. Deasy et. al. Transforming Growth Factor-beta 1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle a key event in muscle fibrogenesis Am J Pathol 164 2004 1007-1019
64. P. Confalonieri P. Bernasconi F. Corneilo et. al. Transforming growth factor beta-1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate J Neuropathaol Exp Neurol 56 1997 479-484
65. K. Amemiya C. Semino-Mora R.P. Granger Down regulation of TGF-beta-1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin Clin Immunol 94 2000 99-104
66. T.J. Broekelmann A.H. Limper T.V. Colby Transforming growth factor beta 1 is present at sites of extracellular gene expression in human pulmonary fibrosis Proc Natl Acad Sci USA 88 1991 6642-6646
67. U. Seeland C. Haeuseler R. Hinrichs et. al. Myocardial fibrosis in transforming growth factor beta 1 transgenic mice is associated with inhibition of interstitial collagenase Eur J Clin Invest 32 2002 295-303
68. A. Childs C. Jacobs T. Kaminski et. al. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise Free Radic Boil Med 31 2001 745-753
69. L.J. Beaton D.A. Allan M.A. Tarnopolsky et. al. Contraction-induced muscle damage is unaffected by vitamin E supplementation Med Sci Sports Exerc 34 2002 798-805
70. Florini D.Z. Ewton S.A. Coolican Growth hormone and the insulin-like growth factor system in myogenesis Endocr Rev 17 1996 481-517
71. R.E. Allen L.K. Boxhorn Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor-I, and fibroblast growth factor J Cell Physiol 138 1989 311-315
72. J.C. Engert E.B. Berglund N. Rosenthal Proliferation precedes differentiation in IGF-1 stimulated myogenesis J Cell Bio 135 1996 431-440
73. S.E. Damon K.L. Haugk R.S. Birnbaum et. al. Retrovirally mediated over-expression of insulin-like growth factor binding protein 4: Evidence that insulin-like growth factor is required for skeletal muscle differentiation J Cell Physiol 175 1998 109-120
74. J.R. Florini D.Z. Ewton S.Z. Falen et. al. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins Am J Physiol 250 1986 C771-C778
75. L.S. Quinn K.L. Haugk Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures J Cell Physiol 168 1996 34-41
76. M.E. Coleman F. DeMayo K.C. Yin Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice J Biol Chem 270 1995 2109-2116
77. M.A. Papadakis D. Grady D. Black Growth hormone replacement in healthy older men improves body composition but not functional ability Ann Intern Med 124 1996 708-716
78. J.C. van Deutekom S.S. Floyd D.K. Booth et. al. Implications of maturation for viral gene delivery to skeletal muscle Neuromuscular Disord 8 1998 135-148
79. J.C. van Deutekom E.P. Hoffman J. Huard Muscle maturation: Implications of gene therapy Mol Med Today 4 1998 214-220
80. K.L. Dreher V. Asundi D. Matzura et. al. Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall Eur J Cell Biol 53 1990 296-304
81. S.N. Giri D.M. Hyde R.K. Braun et. al. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis Biochem Pharmacol 54 1997 1205-1216
82. Isaka D.K. Brees K. Ikegaya et. al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney Nat Med 2 1996 418-423
83. Y.S. Chan Y. Li W. Foster et. al. Antifibrotic effects of suramin in injured skeletal muscle after laceration J Appl Physiol 95 2003 771-780
84. Y.S. Chan Y. Li W. Foster et. al. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury Am J Sports Med 33 2005 43-51
85. H. Mietz G.K. Krieglstein Suramin to enhance glaucoma filtering procedures: A clinical comparison with mitomycin Ophthalmic Surg Lasers 32 2001 358-369
86. P. Kloen C.L. Jennings M.C. Gebhardt Suramin inhibits growth and transforming growth factor beta 1 binding in osteosarcoma cell lines Eur J Cancer 30 1994 678-682
87. W. Foster Y. Li A. Usas Gamma interferon as an antifibrosis agent in skeletal muscle J Orthop Res 5 2003 798-804
88. L. Ulloa J. Doody J. Massague Inhibition of transforming growth factor-beta/SMAD signaling by the interferon-gamma/STAT pathway Nature 397 1999 710-713
89. N.N. Zein Interferons in the management of viral hepatitis Cytokines Cell Mol Ther 4 1998 229-241
90. L. Friedlander D.H. van Thiel H. Faruki et. al. New approach to HCV treatment. Recognition of disease process as systemic viral infection rather than as liver disease Dig Dis Sci 41 1996 1678-1681
91. E.N. Unemori E.P. Amento Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts J Biol Chem 265 1990 10681-10685
92. E.N. Unemori L.B. Pickford Al Salles et. al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo J Clin Invest 98 1996 2739-2745
93. E.J. Williams R.C. Benyon N. Trim et. al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo Gut 49 2001 577-583
94. S. Negishi Y. Li A. Usas et. al. The effect of relaxin treatment on skeletal muscle injuries Am J Sports Med 33 2005 1816-1824
95. Y. Li S. Negishi M. Sakomoto et. al. The use of relaxin improves healing in injured muscle Ann N Y Acad Sci 1041 2005 395-397
96. S. Kapilla Y. Xie Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes Lab Invest 78 1998 925-938
97. J.A. Lenhart P.L. Ryan K.M. Ohleth et. al. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig Endocrinology 143 2002 91-98
98. S. Palejwala L. Tseng A. Wojtczuk et. al. Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endothelial cells Biol Reprod 66 2002 1743-1748
99. L. Song P.L. Ryan D.G. Porter et. al. Effects of relaxin on matrix remodeling enzyme activity of cultured equine ovarian stromal cells Anim Reprod Sci 66 2001 239-255
100. H. Herbst T. Wege S. Milani et. al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis Am J Pathol 150 1997 1647-1659
101. L.J. McClawley L.M. Matrisian Matrix metalloproteinases: They are not just for matrix anymore Curr Opin Cell Biol 13 2001 534-540
102. C. Chang Z. Werb The many faces of metalloproteinases: Cell growth, invasion, angiogenesis, and metastasis Trends Cell Biol 11 2001 37-43
103. G. Gianelli J. Falk-Marzillier O. Schiraldi et. al. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5 Science 277 1999 225-228
104. G. Lluri D.M. Jaworski Regulation of TMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation Muscle Nerve 32 2005 492-499
105. J.F. Woessner H. Nagase Matrix metalloproteinases and TIMPs 2000 Oxford University Press Oxford
106. J.P. Iredale Tissue inhibitors of metalloproteinases in liver fibrosis Int J Biochem Cell Biol 29 1997 43-54
107. R. Lichtenhagen K. Breitenstein B. Arndt et. al. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver Virchows Arch 432 1998 153-158
108. A. von Moers A. Zwirner A. Reinhold et. al. Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy Acta Neuropathol 109 2005 285-293
109. M. Murakami H. Naraba T. Tanioka et. al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 J Biol Chem 275 2000 32783-32792
110. Y. Zhang A. Shaffer J. Portanova et. al. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production J Pharmacol Exp Ther 283 1997 1069-1075
111. R.M. Botting Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? Clin Infect Dis 31 2000 S202-S210
112. B.L. Hirschowitz A. Lanas NSAID association with gastrointestinal bleeding and peptic ulcer Agents Actions Suppl 35 1991 93-101
113. U.A. Boelsterli Mechanisms of NSAID-induced hepatotoxicity: Focus on nimesulide Drug Saf 25 2002 633-648
114. J. Feenstra D.E. Grobee A. Mosterd Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure Drug Saf 17 1997 166-180
115. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232-235
116. L.C. Almekinders J.A. Gilbert Healing of experimental muscle strains and the effects of non-steroidal anti-inflammatory medication Am J Sports Med 14 1986 303-308
117. T.A. Trappe J.D. Fluckey F. White et. al. Skeletal muscle PGF(2)(alpha) and PGE(2) in response to eccentric resistance exercise: Influence of ibuprofen acetaminophen J Clin Endocrinol Metab 86 2001 5067-5070
118. L. Simchozitz J. Metha I. Spilberg Chemotactic factor-induced generation of superoxide radicals by human neutrophils: Effect of metabolic inhibitors and anti-inflammatory drugs Arthritis Rheum 22 1979 755-763
119. D.E. Hammerschmidt P.J. Flynn P.A. Coppo Synergy among agents inhibiting granulocyte aggregation Inflammation 6 1982 169-176
120. S.B. Abramson G. Weissman The mechanisms of action of nonsteroidal anti-inflammatory drugs Arthritis Rheum 32 1989 1-9
121. H.B. Kaplan H.S. Edelson H.M. Korchak et. al. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo Biochem Pharacol 33 1984 371-378
122. V. Prisk J. Huard Muscle injuries and repair: The role of prostaglandins and inflammation Histol Histopathol 18 2003 1243-1256
123. I. Tegeder J. Pfeilschifter G. Geisslinger Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J 15 2001 2057-2072
124. E.V. Cheung J.G. Tidball Administration of the nonsteroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use Inflamm Res 52 2003 170-176
125. P. Gierer T. Mittelmeier R. Bordel et. al. Selective cox-2 inhibition reverses microcirculatory and inflammatory sequelae of closed soft tissue trauma in an animal model J Bone Joint Surg Am 87 2005 153-160
126. D.K. Mishra J. Friden M.C. Schmitz Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but long-term loss of muscle function J Bone Joint Surg Am 77 1995 1510-1519
127. W.T. Obremsky A.V. Seaber B.M. Ribbeck Biomechanical and histiologic assessment of a controlled muscle strain injury treated with piroxicam Am J Sports Med 1994 2258-2561
128. J.A. Paoloni J.W. Orchard The use of therapeutic medications for soft tissue injuries in sports medicine Med J Aust 7 2005 384-388
129. W. Shen Y. Li Y. Tang et. al. NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing degeneration and promoting fibrosis Am J Pathol 167 2005 1105-1118